Walker Michael A
Dart Neuroscience, 12278 Scripps Summit Dr., San Diego, CA 92131, USA.
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5100-5108. doi: 10.1016/j.bmcl.2017.09.041. Epub 2017 Oct 19.
Overcoming poor solubility is a significant issue in drug discovery. The most common solution is to replace carbon atoms with polar heteroatoms such as N and O or by attaching a solubilizing appendage. This approach can lead to other issues such as poor activity and PK or the increased risk for toxicity. However, there are more subtle structural changes which can be employed that lead to an increase in solubility. These include, excising hydrophobic groups which do not efficiently contribute to binding, modifying stereo- and regiochemistry, increasing or decreasing the degree of unsaturation or adding small hydrophobic groups such as fluorine or methyl.
克服低溶解度是药物研发中的一个重要问题。最常见的解决方法是用极性杂原子(如N和O)取代碳原子,或连接一个增溶附属基团。这种方法可能会导致其他问题,如活性和药代动力学较差,或毒性风险增加。然而,还有一些更细微的结构变化可以用来提高溶解度。这些变化包括,切除对结合没有有效贡献的疏水基团,改变立体化学和区域化学,增加或减少不饱和度,或添加小的疏水基团,如氟或甲基。